Objective: Kaliotoxin (KTX) is a neurotoxin purified from Androctonus scorpion venom. Purification and pharmacological and immunological characterization of this neurotoxin has been extensively studied, but its biological effects have not. The ability of KTX to induce neuropathophysiological and immuno-inflammatory effects was investigated. Methods: NMRI mice were injected with a sublethal dose of KTX (20 ng/20 g of body weight) or saline solution via the intra-cerebro-ventricular route. Tissue damage and immunological biomarkers such as eosinophil peroxidase (EPO), myeloperoxidase (MPO), and nitric oxide (NO) were analyzed in serum, brain, lung, and heart tissue. Protein levels, LDH, and CPK activities were also determined in serum 24 h after injection. Results: In this study, KTX injection induced severe alterations in the cerebral cortex, myocardium, and pulmonary parenchyma. Tissue damage was correlated with seric increase in creatine kinase and lactate dehydrogenase activities. KTX also induced an immuno-inflammatory response distinguished by cell infiltration characterized by a significant increase in EPO and MPO activities in the brain, heart, and lungs. This infiltration was also associated with an increase in albumin, α-, β-, and γ-globulin fractions, and NO release. Conclusion: KTX binding to its targets in CNS (Kv1.1 and Kv1.3 channels) may induce severe modifications in the structure and function of various organs associated with the activation of immuno-inflammatory reactions.

Keywords:
Serum proteins, Kaliotoxin, K+ channel, Tissue damage, Eosinophil peroxidase, Myeloperoxidase, Nitric oxide
1.
Gazarian KG, Gazarian T, Hernandez R, Possani LD: Immunology of scorpion toxins and perspectives for generation of antivenom vaccines. Vaccine 2005;23:3357–3368.
2.
Ismail M: The scorpion envenoming syndrome. Toxicon 1995;33:825–858.
3.
Possani LD, Becerril B, Delepierre M, Tytgat J: Scorpion toxins specific for Na+ channels. Eur J Biochem 1999;264:287–300.
4.
Ribeiro EL, Pinto MCL, Labarrère CR, Paes PRO, Paes-Leme FO, Chàvez-Olortegui C, Melo MM: Biochemical profile of dogs experimentally envenomed with Tityus serrulatus scorpion venom. Toxicon 2010;55:1125–1131.
5.
Petricevich VL, Hernandez Cruz A, Coronas FIV, Possani LD: Toxin gamma from Tityus serrulatus scorpion venom plays an essential role in immunomodulation of macrophages. Toxicon 2007;50:666–675.
6.
Petricevich VL: Scorpion venom and the inflammatory response. Mediators Inflamm 2010;2010:903295.
7.
Martin MF, Rochat H: Large scale purification of toxins from the venom of the scorpion Androctonus australis Hector. Toxicon 1986;24:1131–1139.
8.
Bosmans F, Tytgat J: Voltage-gated sodium channel modulation by scorpion α-toxins. Toxicon 2007;49:142–158.
9.
Laraba-Djebari F, Legros C, Crest M, Ceard B, Romi R, Mansuelle P, Jacquet PG, van Rietschoten J, Gola M, Rochat H, Bougis P, Martin-Eauclaire MF: The kaliotoxin family enlarged: purification, characterization, and precursor nucleotide sequence of KTX from Androctonus australis venom. J Biol Chem 1994;269:32835–32843.
10.
Lange A, Giller K, Hornig S, Martin-Eauclaire MF, Pongs O, Becker S, Baldus M: Toxin-induced conformational changes in a potassium channel revealed by solid-state NMR. Nature 2006;440:959–962.
11.
Cologna CT, Marcussi S, Giglio JR, Soares AM, Arantes EC: Tityus serrulatus scorpion venom and toxins: an overview. Protein Pept Lett 2009;16:920–932.
12.
Hammoudi-Triki D, Ferquiel E, Robbe-Vincent A, Bon C, Choumet V, Laraba-Djebari F: Epidemiological data, clinical admission gradation and biological quantification by ELISA of scorpion envenomations in Algeria: effect of immunotherapy. J R Soc Trop Med Hyg 2004;98:240–250.
13.
Hammoudi-Triki D, Lefort J, Rougeot C, Robbe-Vincent A, Bon C, Laraba-Djebari F: Toxicokinetic and toxicodynamic analyses of Androctonus australis Hector venom in rats: optimization of antivenom. Ther Toxocol Appl Pharmacol 2007;218:205–214.
14.
Adi-Bessalem S, Hammoudi-Triki D, Laraba-Djebari F: Pathophysiological effects of Androctonus australis Hector scorpion venom: tissue damages and inflammatory response. Exp Toxicol Pathol 2008;60:373–380.
15.
Sami-Merah S, Hammoudi-Triki D, Martin-Eauclaire MF, Laraba-Djebari F: Combination of two antibody fragments F(ab′)2/Fab: an alternative for scorpion envenoming treatment. Intern Immuno Pharmacol 2008;8:1386–1394.
16.
Bessalem S, Hammoudi-Triki D, Laraba-Djebari F: Effet de l’immunothérapie sur les modifications métaboliques et histopathologiques après envenimation scorpionique expérimentale. Bull Soc Pathol Exot 2003;96:297–302.
17.
Adi-Bessalem S, Mendil A, Hammoudi-Triki D, Laraba-Djebari F: Lung immunoreactivity and airway inflammation: their assessment after scorpion envenomation. Inflammation 2012;35:501–508.
18.
Raouraoua-Boukari R, Sami-Merah S, Hammoudi-Triki D, Martin-Eauclaire MF, Laraba-Djebari F: Immunomodulation of the inflammatory response induced by Androctonus australis Hector neurotoxins: biomarker interactions. Neuroimmunomodulation 2012;19:103–110.
19.
Martin-Eauclaire MF, Bougis PF: Potassium channels blockers from the venom of Androctonus mauretanicus mauretanicus. J Toxicol 2012;2012:103608.
20.
Mourre C, Chernova MN, Martin-Eauclaire MF, Bessone R, Jacquet G, Gola M, Alper SL, Crest M: Distribution in rat brain of binding sites of kaliotoxin, a blocker of Kv1.1 and Kv1.3 alpha subunits. J Pharmacol Ex Ther 1999;291:943–952.
21.
Bessone R, Martin-Eauclaire MF, Crest M, Mourre C: Heterogeneous competition of Kv1 channel toxins with kaliotoxin for binding in rat brain: autoradiographic analysis. Neurochem Int 2004;45:1039–1047.
22.
Bradley PP, Priebat DA, Christensen RD, Rothstein G: Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J Invest Dermatol 1982;78:206–209.
23.
Oswald IP, Gazzinelli RT, Sher A, James SL: IL-10 synergizes with IL-4 and transforming growth factor beta to inhibit macrophage cytotoxic activity. J Immunol 1992;148:3578–3582.
24.
Nathan C, Xie QW: Nitric oxide synthases: roles, tolls, and controls. Cell 1994;78:915–918.
25.
Freire-Maia L: Neurotoxins as tools for physiological investigation. Physiologist 1983;26:381–390.
26.
De Dàvila CAM, Davila DF, Donis JH, De Bellarbarba GA, Villarreal V, Barbosa JS: Sympathetic nervous system activation, antivenin administration and cardiovascular manifestations of scorpion envenomation. Toxicon 2002;40:1339–1346.
27.
Amaral CFS, Resende NA, Freire-Maia L: Acute pulmonary oedema after Tityus serrulatus scorpion sting in children. Am J Cardiol 1993;71:242–245.
28.
Cupo P, Jurca M, Azevedo-Marques MM, Oliveira JS, Hering SE: Severe scorpion envenomation in Brazil: clinical, laboratory and anatomopathological aspects. Rev Inst Med Trop Sao Paulo 1994;36:67–76.
29.
Teixeira CFP, Galante F, Manzoli S, Steil AA, Jancar S: Inflammatory reaction induced by Tityus serrulatus crude venom (TSV) in the lung of rats. J Venom Anim Toxins 1997;3:111–111.
30.
Fabiano G, Pezzolla A, Filograna MA, Ferrarese F: Traumatic shock-physiopathologic aspects. G Chir 2008;29:51–57.
31.
Smith GA: Neutrophils, host defense, and inflammation: a double-edged sword. J Leukoc Biol 1994;56:672–686.
32.
Koo GC, Blake JT, Talento A, Nguyen M, Lin S, Sirotina A, Shah K, MuIvany K, Hora D, Cunningham P, Wunderler DL, McManus OB, Slaughter R, Bugianesi R, Felix J, Garcia M, Williamson J, Kaczorowski G, Sigal NH, Springer MS, Feeneyt W: Blockade of the voltage-gated potassium channel Kvl.3 inhibits immune responses in vivo. J Immunol 1997;158:5120–5128.
33.
Schwartz M: Immunology of the brain: intracranial immune cells are part of the functioning brain and link physiology to pathology. J Neuroimmunol 2010;228:73.
34.
Yu FH, Yarov-Yarovoy V, Gutman GA, Catterall WA: Overview of molecular relationships in the voltage-gated ion channel superfamily. Pharmacol Rev 2005;57:387–395.
35.
Lau D, Mollnau H, Eiserich PJ, Freeman AB, Daiber A, Gehling UM, Brummer J, Rudolph V, Munzel T, Heitzer T, Meinertz T, Baldus S: Myeloperoxidase mediates neutrophil activation by association with CD11b/CD18 integrins. Proc Natl Acad Sci USA 2005;102:431–436.
36.
Anbar M: Nitric oxide: a synchronizing chemical messenger. Experientia 1995;51:545–550.
37.
Annane D, Sanquer S, Sébille V: Compartmentalised inducible nitric oxide synthase activity in septic shock. Lancet 2000;355:1143–1148.
38.
Belenky SN, Robbins RA, Rennard SI, Gossman GL, Nelson KJ, Rubinstein I: Inhibitors of nitric oxide synthase attenuate human neutrophil chemotaxis in vitro. J Lab Clin Med 1993;122:388–394.
39.
Fukuhara YDM, Reis ML, Dellalibera-Joviliano R, Cunha FQC, Donadie EA: Increased plasma levels of IL-1b, IL-6, IL-8, IL-10, and TNF-a in patients moderately or severely envenomed by Tityus serrulatus scorpion sting. Toxicon 2003;41:49–55.
40.
Fukuhara YDM, Dellalibera-Joviliano R, Cunha FQC, Reis ML, Donadi EA: The kinin system in the envenomation caused by the Tityus serrulatus scorpion sting. Toxicol Appl Pharmacol 2004;196:390–395.
41.
Mosmann TR, Coffman RL: TH1 and TH2 cells different of lymphokine secretion lead to different functional properties. Ann Rev Immunol 1989;7:145–173.
42.
Becerril B, Corona C, Garcia C, Bolivar F, Possani LD: Cloning of genes encoding scorpion toxins: an interpretative review. J Toxicol 1995;14:339–357.
43.
Petricevich VL: Balance between pro- and anti-inflammatory cytokines in mice treated with Centruroidesnoxius scorpion venom. Mediators Inflamm 2006;54273.
© 2012 S. Karger AG, Basel
2012
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.